Literature DB >> 5305936

Ototoxicity of gentamicin.

J Wersäll, P G Lundquist, B Björkroth.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5305936     DOI: 10.1093/infdis/119.4-5.410

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  20 in total

Review 1.  Antibacterial Drugs today: II.

Authors:  A P Ball; J A Gray; J M Murdoch
Journal:  Drugs       Date:  1975       Impact factor: 9.546

2.  Serum levels of gentamicin at peak and trough in neonates and infants.

Authors:  M Shahidullah; M Q Talukder; A K Chowdhury; S Ali; A Rashid
Journal:  Indian J Pediatr       Date:  1991 Mar-Apr       Impact factor: 1.967

3.  Distribution of gentamicin in the guinea pig inner ear after local or systemic application.

Authors:  Shun-Ichi Imamura; Joe C Adams
Journal:  J Assoc Res Otolaryngol       Date:  2003-06

4.  Initial changes in the sensory hair-cell membrane following aminoglycoside administration in a guinea pig model.

Authors:  M Takumida; J Wersäll; D Bagger-Sjöbäck
Journal:  Arch Otorhinolaryngol       Date:  1989

5.  [Acute central pontine myelinolysis with multifocal spreading. Observation on dialysis therapy].

Authors:  R von Waechter; B Holdorff
Journal:  Z Neurol       Date:  1973-05-17

6.  Gentamicin in the treatment of gonococcal urethritis. A microbiological, pharmacological, and clinical study.

Authors:  G D Morrison; D S Reeves
Journal:  Br J Vener Dis       Date:  1973-12

7.  Sensory hair fusion in vestibular sensory cells after gentamycin exposure. A transmission and scanning electron microscope study.

Authors:  J Wersäll; B Björkroth; A Flock; P G Lundquist
Journal:  Arch Klin Exp Ohren Nasen Kehlkopfheilkd       Date:  1971

8.  Hearing loss and inner ear changes in a patient suffering from severe gentamicin ototoxicity.

Authors:  R A Tange; E H Huizing
Journal:  Arch Otorhinolaryngol       Date:  1980

9.  Pharmacokinetic and pathological evaluation of gentamicin in cats given a small intravenous dose repeatedly for five days.

Authors:  A D Jernigan; R C Hatch; J Brown; W A Crowell
Journal:  Can J Vet Res       Date:  1988-04       Impact factor: 1.310

10.  Therapy of Pseudomonas aeruginosa infections with tobramycin.

Authors:  D C Blair; F R Fekety; B Bruce; J Silva; G Archer
Journal:  Antimicrob Agents Chemother       Date:  1975-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.